Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

19th Jul 2012 15:44

RNS Number : 0875I
Port Erin Biopharma Investments Ltd
19 July 2012
 



Port Erin Biopharma Investments Limited

 

 ("Port Erin" or the "Company")

 

Director's Dealing

 

 

Port Erin, the AIM listed company focused on investing in the biotechnology and biopharmaceutical sectors, was informed that Galloway Limited purchased 250,000 Ordinary Shares at a price of 7 pence per share on 19th July 2012,

 

Galloway Limited is wholly owned by a trust in which Jim Mellon, Chairman of the Company, has a life tenancy. Denham Eke, a Director of the Company, is a Director of Galloway Limited.

 

Following this transaction, the total Ordinary Shares in which Jim Mellon has a beneficial interest is 4,441,000, representing 13.5% of the issued ordinary share capital of the Company.

 

 

Enquiries:

 

 

Port Erin Biopharma Investments Limited

 

Denham Eke

(+44) 1624 639396

 

 

Libertas Capital Corporate Finance Limited

 

Sandy Jamieson

(+44) 20 7569 9650

 

 

Peterhouse Corporate Finance Limited

 

John Levinson

(+44) 20 7562 3350

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZKLFFLDFZBBL

Related Shares:

Agronomics
FTSE 100 Latest
Value8,774.65
Change-17.15